Home

We are pleased to announce the winners of the inaugural Roy and Diana Vagelos Precision Medicine Pilot Awards. We were impressed with the response and with the broad range of proposals from Columbia faculty.

Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets have just received New York State Department of Health approval and are now available to both oncologists and cancer researchers for use at the front lines of patient care.

“Why is it with all the investment and hard work that we put in to learning about diseases that we still do not have the answer to common complex diseases,” asked Dr. Doug Wallace, PhD, at a talk at Columbia University.